Insights Into Small Cell Lung Cancer (SCLC)
Perspectives on drivers in treatment decisions in the management of lung cancer
West – June 30, 2022
Faculty Chair
Keren Sturtz, MD
Intermountain McKay-Dee Hospital, Ogden, UT, USA
Central – July 11, 2022
Faculty Chair
Janakiraman Subramanian, MD, MPH
Inova Health System, Fairfax, VA, USA
Southeast – August 25, 2022
Faculty Chair
Ticiana Leal, MD
Winship Cancer Institute, Atlanta, GA, USA
More Information
- Virtual series
- California, Nevada, Oregon, Washington, Utah, Wyoming, Arizona, New Mexico
More Information
- Virtual series
- Kansas, Oklahoma, Texas, Missouri, Arkansas, Louisiana
More Information
- Virtual series
- Alabama, Florida, Georgia, Kentucky, Mississippi, North Carolina, South Carolina, Tennessee, Virginia, West Virginia
REPORT SNAPSHOT
- A virtual, moderated roundtable discussion focusing on the treatment of small cell lung cancer
- Disease state and data presentations were developed in conjunction with a national or regional oncology expert
- Insights on the following therapies were obtained on the management of patients with SCLC and therapy strategies in second line and beyond
GEOGRAPHIC REPRESENTATION & CONTENT DEVELOPMENT
- Data collection was accomplished through use of audience response system questioning and moderated discussion
- The group of advisors comprised 10–15 medical oncologists representative of each region
